BioSpace News Archive

Drug Development

Aerpio Asset AKB-9778 Fails to Hit Endpoints in Phase IIb Diabetic Retinopathy Trial

Aerpio said the Phase IIb asset did show some positive data in a number of pre-specified secondary endpoints, including changes in Urine Albumin-Creatinine Ratio, a measure of kidney function, and in intraocular pressure.

March 18, 2019
·
2 min read
·
Alex Keown
Policy

Allergan’s NDA for Migraine Med With Novel Mechanism of Action Accepted by FDA

Allergan, which has been a leader in the migraine space, hopes to have a new treatment available for patients using a new mechanism of action for acute treatment of migraine.

March 18, 2019
·
3 min read
·
Alex Keown
Policy

California Life Sciences Association Names Three Life Science Champions

The life sciences industry is incredibly important to the financial ecosystem of the Golden State. Last year the industry generated total annual revenue of $177.1 billion in the state.

March 18, 2019
·
4 min read
·
Alex Keown
Pharm Country

Women’s History Month: Top Influential Women in Biopharma

March is National Women’s Month with March 8 specifically designated as International Women’s Day. Although this is not remotely a comprehensive list, BioSpace recognizes these 10 women (in no particular order) as being especially influential in the biopharma industry.

March 18, 2019
·
5 min read
·
Mark Terry